Clinical Pharmacology

hVIVO accelerates development via Phase I clinics, human challenge models, biometrics, medical monitoring, and Phase II/III sites across UK & Germany. 
Schedule a Call
hourglass_arrow_up

Expertise

40+ years of early phase expertise 

hub

Experience

Extensive experience across indications; immunology, infectious diseases, dermatology, women’s health, cardiometabolic disorders, renal and hepatic impairment studies

folder_check

Capability

Proven capability running complex FIH studies with integrated SAD/MAD/food effect designs in a single cohesive protocol

circles_ext

Scale

Large Phase I/II clinical units (120 beds) and specialist outpatient infrastructure.

stock-photo-laptop-medical-and-science-with-people-in-laboratory-together-for-breakthrough-or-development-2603761841[1]

What is Clinical Pharmacology?

Our Clinical Pharmacology service provides scientifically rigorous, operationally robust and agile early‑phase clinical trials spanning: 

  • First‑in‑Human (FIH)
  • Single/Multiple Ascending Dose (SAD/MAD) including umbrella protocols
  • Bioavailability/Bioequivalence (BA/BE)
  • Drug–drug and food‑effect studies
  • QT/QTc assessments
  • Vaccine studies
Contact hVIVO

We Support Stuff

Start up

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

contact-bg-image
Learn more

Biotech

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Learn more

Pharma

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Learn more

CRO

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Learn more

Working with hVIVO

Working with hVIVO gives you seamless access to deep clinical pharmacology expertise, specialised early phase infrastructure, and integrated scientific, laboratory and regulatory support that accelerates high quality trials from FIH through Phase II.
Meet the Clinical Pharmacology experts
  1. Study Design & Consulting
    Therapeutic specialists, statisticians, PK/PD modellers and medical leads design programmes optimised for safety, efficiency and regulatory success. 

  2. Participant Recruitment & Screening
    Access to healthy volunteer databases, well characterised patient cohorts in respiratory diseases such as asthma and COPD as well as in cardiometabolic diseases such MAFLD, Diabetes and Cardiovascular, and specialist populations including renal/hepatic impairment. 

  3. Clinical Execution
    Studies conducted in Phase I/II units with pharmacology ready infrastructure—including multifunctional rooms, long stay capacity, and advanced outpatient facilities. 

  4. Bioanalytical & Laboratory Support
    Supported by hVIVO’s accredited virology, immunology, molecular biology, and biomarker labs 

  5. Data Analysis, PK/PD & Reporting
    Integrated biometry, PK, and medical writing teams provide full service analysis packages and regulatory aligned documentation.

  6. Regulatory Support
    Full support from preIND/CTA through global submissions.

hVIVO gives you access to:

Clinical Expertise

  • FIH trial leadership across small molecules, biologics, biosimilars, mRNA, siRNA, and vaccines.
  • Experience in dermatology, women’s health, endocrinology, cardiometabolic 
disease, nephrology, gastroenterology, immunology & metabolic disorders.

Infrastructure

  • 120+ beds across our German Clinics: Large 94bed Mannheim clinic; dedicated renal/hepatic impairment unit in Kiel.
  • Integrated human challenge expertise via purpose built containment level 3 challenge unit.  
pexels-kowalievska-1170979

Case Studies

Case Study

A New Frontier in Respiratory Health: Next-Gen Human Challenges Explained

Andrew Catchpole Chief Scientific Officer
04 Mar 2026 6 min read
View
01

A New Frontier in Respiratory Health: Next-Gen Human Challenges Explained

Case Study

Beyond Traditional Studies: The New Era of Respiratory Virus Human Challenge Models

Andrew Catchpole Chief Scientific Officer
04 Mar 2026 6 min read
View
02

Beyond Traditional Studies: The New Era of Respiratory Virus Human Challenge Models

Scientific Publication

The Future of Virology: How Next-Gen Human Challenge Models are Breaking Barriers

Andrew Catchpole Chief Scientific Officer
03 Mar 2026 6 min read
View
03

The Future of Virology: How Next-Gen Human Challenge Models are Breaking Barriers

Scientific Publication

Refining Viral Pathogenesis Studies via Advanced Human Challenge Frameworks

Andrew Catchpole Chief Scientific Officer
03 Mar 2026 14 min read
View
04

Refining Viral Pathogenesis Studies via Advanced Human Challenge Frameworks

Case Study

Advancing Respiratory Virus Research Through Next‑Generation Human Challenge Models

Andrew Catchpole Chief Scientific Officer
03 Mar 2026 11 min read
View
05

Advancing Respiratory Virus Research Through Next‑Generation Human Challenge Models

    FAQ

    Still have questions?
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
    Get in touch with us

    Yes — our teams manage both HV and special populations including renal/hepatic impairment, elderly cohorts, and women specific studies.

    Yes — our teams manage both HV and special populations including renal/hepatic impairment, elderly cohorts, and women specific studies.
    Yes — our teams manage both HV and special populations including renal/hepatic impairment, elderly cohorts, and women specific studies.
    Yes — our teams manage both HV and special populations including renal/hepatic impairment, elderly cohorts, and women specific studies.
    Can you run integrated protocols incorporating healthy volunteers and patient populations?  
    Can you run integrated protocols incorporating healthy volunteers and patient populations?  
    Do you offer integrated PK/PD modelling?
    Can you run integrated protocols incorporating healthy volunteers and patient populations?  
    Do you offer integrated PK/PD modelling?

    Meet Our Experts

    expert1

    Name Surname

    Title, department description

    Lorem ipsum dolor sit amet consectetur. Imperdiet facilisis phasellus curabitur suscipit dui. Ultricies tristique sit nunc mauris faucibus ac sit. Aliquet vulputate a tellus in fringilla.

    expert2

    Name Surname

    Title, department description

    Lorem ipsum dolor sit amet consectetur. Imperdiet facilisis phasellus curabitur suscipit dui. Ultricies tristique sit nunc mauris faucibus ac sit. Aliquet vulputate a tellus in fringilla.

    expert3

    Name Surname

    Title, department description

    Lorem ipsum dolor sit amet consectetur. Imperdiet facilisis phasellus curabitur suscipit dui. Ultricies tristique sit nunc mauris faucibus ac sit. Aliquet vulputate a tellus in fringilla.

    expert4

    Name Surname

    Title, department description

    Lorem ipsum dolor sit amet consectetur. Imperdiet facilisis phasellus curabitur suscipit dui. Ultricies tristique sit nunc mauris faucibus ac sit. Aliquet vulputate a tellus in fringilla.

    Plan your next Clinical Trial with hVIVO

    If you're a potential customer, find out how hVIVO can help you.

    Enquire now